Safety Tolerability and Pharmacokinetics of GIC-1001 Following Multiple Ascending Doses Administrations Through an Adaptive First-in-Human Study in Healthy Volunteers
Cognitive Performance and Psychedelic Effects Following Single and Multiple Ascending Doses of a New Cannabis Formulation
VIDEO — Does Your Bioanalytical Partner Have What it Takes?
|
|
|
Discover how Altasciences delivers comprehensive bioanalytical solutions through all phases of your drug development journey. Using the latest technologies and scientific know-how, we bring your vision to life. |
|
|
|
|
|
|
Determination of Pirfenidone and Metabolites in Rat Plasma by Coupling On-Line Fractionation with LC-MS-MS
Microsampling - Making a Difference in Drug Development
Microsampling volume
Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant ad
GEN: Roviant Sciences - Gimsilumab
Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
NHP Supply and Study Start Assurance
|
|
|
Altasciences is always looking ahead. Our team of experts planned for potential shortages of nonhuman primate (NHP) supply, and took action to guarantee access. To ensure NHP supply and on-time study start dates, Altasciences entered into a four-year agreement to secure Cambodian primates. |
|
|
White Paper – Nano Particulate Formulations
|
|
|
The most common reason for producing sub-micron or nano-sized dispersions is to increase oral bioavailability of poorly soluble drugs. In this white paper, Alliance Contract Pharma, an Altasciences company, explains how other routes of administration can also benefit from the smaller format. Alliance Contract Pharma joined the Altasciences family in February 2020. We offer 25 years of experience in pharmaceutical manufacturing and laboratory operations in a wide range of dosage forms. |